Cargando…
Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression
Ketamine’s pharmacological profile makes it an interesting and useful drug to challenge treatment-resistant-depression (TRD). Emerging adverse events associated with single-slow-sub-anaesthetic doses for the treatment of depression are common, although generally transient and self-limited. Neverthel...
Autores principales: | Gómez-Revuelta, Marcos, Fernández-Rodríguez, María, Boada-Antón, Laura, Vázquez-Bourgon, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768831/ https://www.ncbi.nlm.nih.gov/pubmed/33489089 http://dx.doi.org/10.1177/2045125320981498 |
Ejemplares similares
-
Association between plasma levels of BDNF and the antisuicidal effects of repeated ketamine infusions in depression with suicidal ideation
por: Zheng, Wei, et al.
Publicado: (2020) -
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
por: Matveychuk, Dmitriy, et al.
Publicado: (2020) -
Human induced pluripotent stem cells technology in treatment resistant depression: novel strategies and opportunities to unravel ketamine’s fast-acting antidepressant mechanisms
por: Marcatili, Matteo, et al.
Publicado: (2020) -
Gut feeling: randomized controlled trials of probiotics for the treatment of clinical depression: Systematic review and meta-analysis
por: Nikolova, Viktoriya, et al.
Publicado: (2019) -
What combinations of agomelatine with other antidepressants could be successful during the treatment of major depressive disorder or anxiety disorders in clinical practice?
por: Potměšil, Petr
Publicado: (2019)